35 results match your criteria: "Institut Hospitalo-Universitaire de Strasbourg[Affiliation]"
Ann Surg
November 2015
*Hôpital Paul Brousse, Villejuif, France †Institut Mutualiste Montsouris, Paris, France ‡Gustave Roussy, Villejuif, France §Hôpital Hautepierre, Strasbourg, France ¶Hôpital Henri Mondor, Créteil, France ||Center Hospitalier Universitaire, Nancy, France **Center Hospitalier Régional Universitaire, Montpellier, France ††Nouvel Hôpital Civil, Institut Hospitalo-Universitaire de Strasbourg, Strasbourg, France.
Objective: To compare early and long-term outcomes in patients undergoing resection for colorectal liver metastases (CLM) by either a laparoscopic (LA) or an open (OA) approach.
Background: The LA is still a matter of debate regarding the surgical management of CLM.
Methods: Data of all patients from 32 French surgical centers who underwent liver resection for CLM from January 2006 to December 2013 were collected.
World J Gastrointest Pharmacol Ther
November 2015
Jean-Baptiste Delhorme, Riccardo Méméo, Jacques Marescaux, Patrick Pessaux, Institut Hospitalo-Universitaire de Strasbourg, Nouvel Hopital Civil, Hôpitaux Universitaire de Strasbourg, 67091 Strasbourg, France.
A 53-year-old woman underwent a 2-stage right hepatectomy for bilobar metastasis of an ileal neuroendocrine carcinoma. Preoperative three-dimensional computed tomography reconstruction helped to diagnose an intrahepatic venovenous shunts from the right and middle hepatic veins to the left hepatic vein, which could cause a intraoperative bleeding. Hemostasis was performed by means of precoagulation with microwave-assisted coagulation.
View Article and Find Full Text PDFOncogene
June 2016
INSERM UMR 866, « Equipe labellisée» Ligue National contre le Cancer and Laboratoire d'Excellence LipSTIC, Dijon, France.
Graft versus host disease (GvHD), which is the primary complication of allogeneic bone marrow transplantation, can alter the intestinal barrier targeted by activated donor T-cells. Chemical inhibition of the stress protein HSP90 was demonstrated in vitro to inhibit T-cell activation and to modulate endoplasmic reticulum (ER) stress to which intestinal cells are highly susceptible. Since the HSP90 inhibitor 17-allylamino-demethoxygeldanamycin (17AAG) is developed in clinics, we explored here its ability to control intestinal acute GvHD in vivo in two mouse GvHD models (C57BL/6BALB/c and FVB/NLgr5-eGFP), ex vivo in intestine organoids and in vitro in intestinal epithelial cultures.
View Article and Find Full Text PDFJ Hepatobiliary Pancreat Sci
May 2015
Institut de Recherche contre les Cancers de l'Appareil Digestif (IRCAD), Strasbourg, France; Institut Hospitalo-Universitaire de Strasbourg (IHU), Institute for Minimally Hybrid Invasive Image-Guided Surgery, Université de Strasbourg, Strasbourg, France; Division of General Surgery, Sunnybrook Health Sciences Centre - Odette Cancer Centre, Toronto, Ontario, Canada.
Pre-operative simulation using three-dimensional (3D) reconstructions have been suggested to enhance surgical planning of hepatectomy. Evidence on its benefits for hepatectomy patients remains limited. This systematic review examined the use and impact of pre-operative simulation and intraoperative navigation on hepatectomy outcomes.
View Article and Find Full Text PDFLangenbecks Arch Surg
April 2015
Institut Hospitalo-Universitaire de Strasbourg (IHU) Digestive and Endocrine Surgery, Nouvel Hôpital Civil, University of Strasbourg, 1, Place de l'Hôpital, 67091, Strasbourg, France,
Background: Augmented reality (AR) in surgery consists in the fusion of synthetic computer-generated images (3D virtual model) obtained from medical imaging preoperative workup and real-time patient images in order to visualize unapparent anatomical details. The 3D model could be used for a preoperative planning of the procedure. The potential of AR navigation as a tool to improve safety of the surgical dissection is outlined for robotic hepatectomy.
View Article and Find Full Text PDFHepatobiliary Surg Nutr
August 2014
Institut de Recherche sur les Cancers de l'Appareil Digestif (IRCAD)-Institut Hospitalo-Universitaire de Strasbourg (IHU Mix-Surg), Strasbourg, France.
Hepatobiliary Surg Nutr
April 2014
1 Pôle Hépatodigestif, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France ; 2 Service de Chirurgie Générale, Digestive et Endocrinienne, Hôpital Robert Debré, Centre Hospitalier Universitaire de Reims, Université de Reims Champagne-Ardenne, Reims, France ; 3 INSERM, Unit 1110, Université de Strasbourg, Strasbourg, France ; 4 Institut de Recherche sur les Cancers de l'Appareil Digestif (IRCAD)-Institut Hospitalo-Universitaire de Strasbourg (IHU Mix-Surg), Strasbourg, France.
Background: Laparoscopic liver resection (LLR) is growing in popularity, but the short- and long-term outcome of patients undergoing LLR for hepatocellular carcinoma (HCC) has not yet been established.
Methods: A literature search was performed using PubMed, Scopus, and Web of Science (WoS) from cited English and Chinese publications. Clinical and survival parameters were extracted.